Assignment of the protein kinase homolog of YAK1 (HIPK3) to human chromosome band 11p13 by in situ hybridizationNUPPONEN, N. N; VISAKORPI, T.Cytogenetics and cell genetics. 1999, Vol 87, Num 1-2, pp 102-103, issn 0301-0171Article

Steroids and prostate cancerCUNHA, G. R; TUOHIMAA, P; VISAKORPI, T et al.Journal of steroid biochemistry and molecular biology. 2004, Vol 92, Num 4, issn 0960-0760, 109 p.Serial Issue

High cell proliferation activity determined by DNA flow cytometry and prognosis in epidermoid lung carcinomaVISAKORPI, T; HOLLI, K; HAKAMA, M et al.Acta oncologica (Stockholm). 1995, Vol 34, Num 5, pp 605-609, issn 0284-186XConference Paper

Smoking and survival from lung cancerHOLLI, K; VISAKORPI, T; HAKAMA, M et al.Acta oncologica (Stockholm). 1999, Vol 38, Num 8, pp 989-992, issn 0284-186XArticle

Androgen receptor gene amplification in a recurrent prostate cancer after monotherapy with the nonsteroidal potent antiandrogen casodex (bicalutamide) with a subsequent favorable response to maximal androgen blockadePALMBERG, C; KOIVISTO, P; HYYIINEN, E et al.European urology. 1997, Vol 31, Num 2, pp 216-219, issn 0302-2838Article

Small subgroup of aggressive, highly proliferative prostatic carcinomas defineb by p53 accumulationVISAKORPI, T; KALLIONIEMI, O.-P; HEIKKINEN, A et al.Journal of the National Cancer Institute. 1992, Vol 84, Num 11, pp 883-887, issn 0027-8874Article

Association of overexpression of tumor suppressor protein P53 with rapid cell proliferation and poor prognostic in node-negative breast cancer patientsISOLA, J; VISAKORPI, T; HOLLI, K et al.Journal of the National Cancer Institute. 1992, Vol 84, Num 14, pp 1109-1114, issn 0027-8874Article

Cerebrospinal fluid lactoferrin in bacterial and viral meningitisVISAKORPI, T; VILJA, P; KULOMAA, M et al.Acta paediatrica scandinavica. 1987, Vol 76, Num 6, pp 987-988, issn 0001-656XArticle

Mutation analysis of aryl hydrocarbon receptor interacting protein (AIP) gene in colorectal, breast, and prostate cancersGEORGITSI, M; KARHU, A; WINQVIST, R et al.British journal of cancer. 2007, Vol 96, Num 2, pp 352-356, issn 0007-0920, 5 p.Article

Hormonal, cellular, and molecular regulation of normal and neoplastic prostatic developmentCUNHA, Gerald R; RICKE, Will; THOMSON, Axel et al.Journal of steroid biochemistry and molecular biology. 2004, Vol 92, Num 4, pp 221-236, issn 0960-0760, 16 p.Article

Androgens, lipogenesis and prostate cancerSWINNEN, Johannes V; HEEMERS, Hannelore; VAN DE SANDE, Tine et al.Journal of steroid biochemistry and molecular biology. 2004, Vol 92, Num 4, pp 273-279, issn 0960-0760, 7 p.Article

Sex steroid hormone metabolism and prostate cancerSORONEN, P; LAITI, M; ISOMAA, V et al.Journal of steroid biochemistry and molecular biology. 2004, Vol 92, Num 4, pp 281-286, issn 0960-0760, 6 p.Article

Hormone-resistant prostate cancer with symptomatic pelvic tumours : patient survival and prognostic factorsHERNES, E. H; LINJA, M; FOSSA, S. D et al.BJU international (Papier). 2000, Vol 86, Num 3, pp 240-247, issn 1464-4096Conference Paper

In vivo amplification of the androgen receptor gene and progression of human prostate cancerVISAKORPI, T; HYYTINEN, E; KOIVISTO, P et al.Nature genetics. 1995, Vol 9, Num 4, pp 401-406, issn 1061-4036Article

Flow cytometric analysis of DNA ploidy and S-phase fraction from prostatic carcinomas : implications for prognosis and response to endocrine therapyVISAKORPI, T; KALLIONIEMI, O.-P; PARONEN, I. Y. I et al.British journal of cancer. 1991, Vol 64, Num 3, pp 578-582, issn 0007-0920Article

Changes in circulating microRNA levels associated with prostate cancerBRYANT, R. J; PAWLOWSKI, T; CATTO, Jwf et al.British journal of cancer. 2012, Vol 106, Num 4, pp 768-774, issn 0007-0920, 7 p.Article

The methyl-CpG-binding protein MECP2 is required for prostate cancer cell growthBERNARD, D; GIL, J; DUMONT, P et al.Oncogene (Basingstoke). 2006, Vol 25, Num 9, pp 1358-1366, issn 0950-9232, 9 p.Article

Role of estrogens in development of prostate cancerHÄRKÖNEN, Pirkko L; MÄKELÄ, Sari I.Journal of steroid biochemistry and molecular biology. 2004, Vol 92, Num 4, pp 297-305, issn 0960-0760, 9 p.Article

Androgen receptor gene mutations in hormone-refractory prostate cancerWALLEN, M. J; LINJA, M; KAARTINEN, K et al.Journal of pathology. 1999, Vol 189, Num 4, pp 559-563, issn 0022-3417Article

Genetic alterations in hormone-refractory recurrent prostate carcinomasNUPPONEN, N. N; KAKKOLA, L; KOIVISTO, P et al.The American journal of pathology. 1998, Vol 153, Num 1, pp 141-148, issn 0002-9440Article

Low biological aggressiveness of screen-detected lung cancers may indicate over-diagnosisHAKAMA, M; HOLLI, K; VISAKORPI, T et al.International journal of cancer. 1996, Vol 66, Num 1, pp 6-10, issn 0020-7136Article

Prognostication of astrocytoma patient survival by Ki-67 (MIB-1) PCNA, and S-phase fraction using archival paraffin-embedded samplesSALLINEN, P. K; HAAPASALO, H. K; VISAKORPI, T et al.Journal of pathology. 1994, Vol 174, Num 4, pp 275-282, issn 0022-3417Article

New prognostic factors in prostatic carcinomaVISAKORPI, T; KALLIONIEMI, O. P; KOIVULA, T et al.European urology. 1993, Vol 24, Num 4, pp 438-449, issn 0302-2838Article

Association of c-erbB-2 protein over-expression with high rate of cell proliferation, increased risk of visceral metastasis and poor long-term survival in breast cancerKALLIONIEMI, O.-P; HOLLI, K; VISAKORPI, T et al.International journal of cancer. 1991, Vol 49, Num 5, pp 650-655, issn 0020-7136Article

The epidemiology of sex steroid hormones and their signaling and metabolic pathways in the etiology of prostate cancerPLATZ, Elizabeth A; GIOVANNUCCI, Edward.Journal of steroid biochemistry and molecular biology. 2004, Vol 92, Num 4, pp 237-253, issn 0960-0760, 17 p.Article